Production (Stage)
ZyVersa Therapeutics, Inc.
ZVSA
$0.59
$0.000.00%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.26% | 1,145.65% | 2.85% | -94.12% | -35.19% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 169.77% | -30.88% | -48.74% | -39.77% | 302.09% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 22.99% | 339.50% | -39.13% | -77.88% | -13.51% |
|
|||||
Total Current Assets | 22.99% | 339.50% | -39.13% | -77.88% | -13.51% |
Net Property, Plant & Equipment | -- | -- | -- | -60.47% | -70.95% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -3.56% | -38.87% | 116.02% | 81.22% | 0.00% |
Total Assets | 1.87% | 6.05% | -0.23% | -10.07% | -2.10% |
|
|||||
Total Accounts Payable | 2.86% | 0.57% | 11.64% | 2.32% | -3.60% |
Total Accrued Expenses | 26.76% | -16.15% | 34.65% | 15.43% | 16.07% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | -98.56% |
Total Other Current Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | -98.56% |
Total Current Liabilities | 6.88% | -2.69% | 15.48% | 4.30% | -6.00% |
|
|||||
Total Current Liabilities | 6.88% | -2.69% | 15.48% | 4.30% | -6.00% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 0.00% | -0.34% | 0.00% | 1.15% | 0.00% |
Total Liabilities | 6.39% | -2.53% | 14.26% | 4.05% | -5.54% |
|
|||||
Common Stock & APIC | 1.54% | 2.46% | 0.69% | 0.14% | 2.60% |
Retained Earnings | -2.00% | -1.28% | -2.21% | -2.61% | -2.74% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | -4.53% | 21.19% | -18.48% | -23.19% | 1.34% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -4.53% | 21.19% | -18.48% | -23.19% | 1.34% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -4.53% | 21.19% | -18.48% | -23.19% | 1.34% |
|